GSK and Google Parent Forge $715 Million Bioelectronic Medicines Firm

JFIF;CREATOR: gd-jpeg v1.0 (using IJG JPEG v62), quality = 80 C   %# , #&')*)-0-(0%()(C   ((((((((((((((((((((((((((((((((((((((((((((((((((( " }!1AQa"q2#BR$3br %&'()*456789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz w!1AQaq"2B #3Rbr $4%&'()*56789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz ?LHGEhcf>ժ~U+KpE.:=>4 QN/j@o+LVfƦO8ޒ*[l- D&t0]*a oKT}WkN >6wP^E[J'S5a2&T˽23ou=fjݥwc`'r:G)6RI ]4M??X6ƅf">7~εY]&͑ 簯5.lm梤csj4Y^I{vݘ),y,zYc+XMjiO1rO3^dj1QVGM/e2)_I@Zq8?A^ wD M{NkO%6&ϊpiqd8S֚< P)R-K)hQR(%$;uF}QQ~:RGtsգ 嚹DxLeC ܾWojvn"#Akzr0 &(Zk'FCln[WůGY,ekk>8`[_.S+gJ.igl0GG&z?ku .RfI%(Ytl[h--5[o= HAqQkNI8ɕIRT&yxmҷlMmh1$5/? ;,dގOU>2N5f.&ot򩼿0!bSGxU?Hգ%HPkdkɼ3=\yR9]H8PXoO oJ>,z|zf&3?xv8^CeŸoZ-?- t8_]DH ;rNv(dQL((.(Rh(RR@ ESCRZ)JJSAKE6E0HE) /jon) `6Z)ozv))(COhCh4mP HiqHE%&)ƐHS 4HhĤ %;o~jA1UPR)i+Ds})SS ^ Z@fCti⳴эWTz3ӤĥK1@Q SlzEŤQ'lYkfrĎ5%'|Fz)7\g?In@Lb^'"C^yt=Cz< 7B5}Qkl&F+bKIsQ_celO9ֺ^]Сګ{ס0/m뽳W4ާV,=} w:>"lОW-e+"mfl#lQ_3+UINtibpԕh˙nב̨TWCvH]RўLc=0Gj\YaT$AS2瑴(HfؙZc/cm1z$l#oQNu{"[jѬpeN|MaP0HmR0ʑa1rZ.tbX_ze 05Wl|]5rڪcԸaխQ"+jR IhOPsu5Ky~1J1^59FsHE уh5kyX#r+mCq[|͑c8Ǧ {VSYȭwtǷ fwg(9W5x8ՋGU %sӵS)޻sֻM#J_CZ8ϥy ['Lo^2akA(+qhJ6(s׾3=̓coP@ 8%FE\i4f ȤLƺ9xХ@aЏ`~2\.j(oSne[k+Tk=N 1U?W^[ . nWiO/Xۼ\ cxok?wXR7= K5iW 8t>V|ۯxC]6O//;pEe4vZ'}cW_Fe:ZsCTze *(((((@ E-!"ZJ(SLii)Ԙ1(4Q@ HE)tqHE8)()SORbڒ⒜iM ө(44ъS%P4`4ъZC@ ޒM:i)i( gYjzi:?¯!յ!vJAVw環M!”R p@?_SПѫLVmƷ$TQޖ#Qw1;AQ&n"~a"[#~ ko׋!bell\GiyڥO.Uk,Oys;]=㺃J_wJ LJyd` +_C59A-Ǧ9j*jt`j{,DeQ 5ͱ< \]_/NbruOQ\XQoİuAa9VN9X H CmQć=EǗU%hKi4xwzaxk+6;UO4o .t8wڸɣ~u'B;;rTz}ᰴXTa~wǾMVlu-dxa,4ҳ9.&$Q(%⢺c{qSip?q٩F9A KI[hh%G^kֆt~xF4N Rnn7Z:dze+2^$VfP緺R;{Lҵ ovk-x֗ ÎPZ9V  5{+mZm{~Su=p}TOr[pnKp'ѿ>>_JKN;ս-RH#%HsqOMI] ZQ|c{jFt ?j3$:Awp_2hU,Ŝ*9Y: A k}>(Ae$ՏVڽIԬk㸷pB;c\xm#hF}G>6ឬV]KZ߷ִqF\tgtW/:_"MMG-d쇑 ʿvT;\~5e~iۊj QUmNc>Ӎ{Pf[Xc 1IB u1EPD+q0fIW?^,=\wk.ewsFӹՆ2=ZI"}Ylˠ̇#qJrz֞]QCi\ OX}:ipI$>Ս?>}rT;Mv xG{yN ++tze?wwKCJ][qUW4n.WCƄ`?T r:EvQIt3эzr.}żWP78+ +akHgؐy- #>qϷ5M8H7TL)A`Ҿ5b~W.|5IS}47Ɲ]OB&1MTA)܅,V#B Jzbh)SںIEktQt-D:}g~Fqr:J@'Mr2㸳,D[Nْ{jqyy7ZyarSUمCe{X,g"xť*d/ v<^|5t}d?%Œ7IQKDYQ_K[[ص0m(FGkhZ桦M̆sH*+j j)%#ȴE&;NQwd=uYAgYGn7@>_nL r]ȒCR~k ),۟t6W9'YT4tš=)'Ҕt^/2UGTcVER3~b((h#ӏIQu? j̋^jz]H?QZG ]X.Y]$L2U:iķX!Bct]Jz}rkGsci,%ggiuw˺uFL??uJ*G+eyr꬧ƕ@#~%^緵q:'Qgkï]V7B1q,WnᇉJ v7&ƕN9-nڔô^x>kZsjKMN><<]j, Q-WWa_=xvׅZdO'cmZV1i ts&?*J}[RsҺǫ@E3(((`QE S(CKE%!ihB)ؤ1R(h4S)yh44M>s@ 4i0ԇ%!=iJCKHiLC(E6ZJN4P { hq'~Z1{ K@-gljͿ5#YF8CZӡ.+2 | 0'ٲ*^B/?N@i9#A֗ha)w"-$gBLi٭nO&HΣm͟Y~!u_Q~%ц}+KeR0h] ˰*xI<㦌J/S~U㒎3_TJMoA!Ix&OPAW& 49_BIn%GӔs;z̾K[J~aG_W~ tJ5mr> 7 W?uq/DG2!ݡl~ YNGVQNZ oFS_iFSğz7FI_uNϞ?4d}E.:~Ҟs#VއG]BM:$F"2@uVBmoPw3x9>{ΩÞLZj.u+ѭ:.Z۰/ Ǩ=zf[Y)УPitF}:IOCхvPOk"2Դ/3G*sijoAY^%JĞo,kDGК,!ʀy9KoC%UϮmsWW(/uU2r@WV66h'4{A ݆c1zrzocΣF<=b\\q)yX/j#CHMy.}#(5B#(`?.ΙR uurJ2AOI%ިiVZ<>|]{m~ؒJ0z8c=GEFhSZpwC4Oi:L6ןhTKW1?ҷ4m裖ݝ&K ^}>FUU̽GOUlW9yOl&jO V/WewZ{.d"y5O2ڇ J;{\vk6::Oo GP}kBjۅQLAER((((4))h=)AT4Ĥ4aM"I@iԆE1 4Mi 8h))ؤ4Jm:"NԦIL"SI@ĢR/tyxu3P^Kt.+QpRƵ})k^BB<ǧQYEYI #BXOXͩFPvRKZq+o{g֭eq UB*BSJJpHKh 0,kix*lBjqyY6GdJ=AE45B-/ @);cG>M˃W  ?ZJ> 6& OTap3#N+/^gI=yB6z8{ )Arl맆 s*jTrIR:pjigN3Lj=Bi{`2OVjZ'W)6TPZu\B*qQn4d!]{٬x12A\Kp3j-ٹK_"QK#5*(Wpaָ kJW[3|7N_tMFƔjEDv!@5G{i+So/y]EVsVڗ rFªW!I#ηN~b>%W'AїSYR~M++5JmG[J2'QE-SÖPhP˜p nQЮz>$]˧xfHd ARpD}Jt^êP}kgᛝ.a9qJ0}>}>Q3<ñfi׀c:A.u}Ej]2ѣE𬢥NnFGBSu,sZOS=aלko֯zUnWRHb/  qJ0 סNgYգ*z4%8R QZz(RQUU;!BE1M wdF RъbGԣis~dNkh%ń|(a6si\Y&aܮwy|G2$czvX+~;'.7e$c[Q5#̎)t{4s VD8":-ka)8V,x54xh RԀ8:_ )VI5C;/ޙ~^F; :ߋXꁁ*ҴO<Нޚ{ih1Iw ]vγd\Lc8ZQ驦H~aGON?J-iQ# gWv/!w9f99GJ]i.~Ѷ HBkRWz~eЪVUd> Sַ;Fua `zՎ0)iȲ =UKV*x3U8.bk%k$OOb=j5}zIhWylGA>ۡrZ3ji426=_A[uo$8!AJ@"kF āp3oϞk jO e5FoS\3yO{{7}5;Sny'c 6l2 Y8 3\]g} Nyxjdzw 5[U["Yo᥎N#ds7 &4$2{7CWľD".|订9\=oxR4y5),opǯSmE)MhTn&7.:&{Q赿/J׊ImYojtz\Mk5Ǟem Z]DS@SQa'u>ҴWC'$=mT *exca]M{׹#,2 Z&Z7f-QAQEQEQEPh E-%0bI@ QTPfZm4q=)!hLbM4CҨCi;Ri4SBi)JJSI) -R@+4RhՔ8"G<K'?VS+}E W tz/QOG=מțf:{"Iw'~4gVcCuf(xaVqqt$?FBT_8;5PR*1Ѥk~Υm­D@Xz=W8̥1)AEd(H :^}ݏާXִl e4g(kk|?uGzFj<ڔeMHj?ҮPJajYSyO >j40o½"Mϡ^Fdfq捙)I4|r*'5SwR37&>pkʔy]BjjjVU+mnb6H֝8=*lYgj`o{ǕqT>O֓yW+x6Zevi^.Ogg IS}ѝj 13T;u[oh\C% yytaY:O+MI]["*k$C#)5TxoI1Re#|{cw`۳?Z[Zt(ID.{7_Cȋ"2H# _xIHʏfC#~kȁhؓu?$wKԼepk# r ݸۋpІ"8t$GO^Ow_<#>^ ]`,98气y{/='L94dGoQjNmw=HrJ_$:m$#f 0o~S]qKX& & {itgE^oіm_[y8 +L=Gj{LN7LS U# 8~ۓqd7oZZqZ7& HN?"q᪵xk9 ]<[b M%Wsrÿõu3{oIs%2I1zzjB4oL xXz=GQTM^M` r٪RUl9kkHmUKZ&J~(rב\z5 { @ixXy cI,7.Rq*TquydmIgmҗv<*xNd5,8mڷO"|*5/&$0y e'[ӧt&𝦼f d*yóרQTxL'>\wmŬ,2(eu9T¾so?cnܣ}k-/P,bfnWSySRWG%JN-QGZ)%/Z((((`%)oz)i) CKHiCIN<})M%2BiԔiKHii)hCi)Rc֘i ) 4RJCHii 0>QW渽2vM?uj݊X\Yim0+wk 4VD e@G#xgf9amW̖ڗ2 Mk|y}e;Ԉ;MR.?Z~lVp27QVl]єभ$r:$׏:bHsU#Յec`8ִkvOߜoO ^*Fj<Ӕ?hU xĖMSQܡ Zخߺ68"pwjrFVE[f5{C*Olyp2џ=}:0I|L5- AQaʸSV3!y5=I]J Ki6hR+8<>/tiTہ0c V `CWZ}os#>^x#\CLxQ{ӟ'JfΚP:1Nj6s$ =_ZK zY^Y܃\+>.ExkFCnD ~|ּ:f򋛁ȅ:UFghC>Vc~wQWE_.8_zp U,d|6 S[51厑ZK6y+t#h+RWpN"D{ݎx\Z2HWxp8FSAzc^wf_jfѽg9R I4Nsm#79pZגƾ[Ӯ1r &r%#ͺ=߆+%MN (OZCMx)|Aa+mBw>(o0Լ ?˺~2WMxTQUI U UFHیzRYk~xAg2njTzUΚ73Q|6;?5hT%zdZ|)3U˫u=?Ҽ+ZUcn#! 1 s־"gí; ֣PVF0ܕ: ?ǡ4סusɒhJSO?ZSԇlqi)Q2<k= 1QEN3E֯){ Z'`?C_E20"k:^iH<2lx?NUuG_ݑW5ck 7EJDkqV%;\Cmuv f,+#%G_F]q4@אKHrq_XAD]S"u$O:׿ƭa:ȣt~P]՗ǨҪi[ܤ2ʀ''z3XwQڥƒ"FF HlgV\Dʔ9#GQӭ5a,l~c:GO~>7j,I3((osyeOr}P 5,u+`yR&$\r5)TV] w<VGg Nr_m}l$#:6qֵLG` ]6mؑP'\cdPCʆ#O_ʰj5u+N S0ujYkyMcVMrO{^qjOb10\]>.#iĊw;7~Yz-pލ)l`}f&y|oM;ysY8eos+I֗͵VX\ oqo&$,eC<;XKMe#<#Cko]ZHen!Eñ NF˺3Ĉ~M[\%J|)h♐RmP!(RM4өJJi:Pt4M!)JZJbM4CLCi)ƒRJiъ`6HiRi 3i?Wm)mUD&U|6 I>ͻZQڼGϠRh}F%Ɍ:ʥ&/Gދ/ !嵿}WIo(ZF |UYJ*͌"akA$uVP0`)ʟxЀ_W3ML)PoQֳoeXWUhWMVE!1UtK|5_&Y?=FN{"ZkyS}œ']M+HסD%Ut<n)<9*%'G֬5xY\+69C/Uyy_9k/$k$`wm~͡dW W/tҪnO ZdSWo:T^gB$e^GU:֐(;ŘΚG)ue-;++'W\75FASGdo"2r1^,jj<o9* ҭVE*#)+͜%i^!l|A`ֺ!ת8>׆: ՇirFAǭMJJfqPxȥӌdW"u<\ÝLh ye?p΄ztpaJ:՘d Z?JB|ri1E¸_ϡsSSwϧ^iچ9Ur?{^',^N8x(>n1hHiOoGPU A]Ek#9H \o]rf  㞞k{Oֱ,em.E@6myVeVaZw//t4RV 0Az:b9̈́s~L zċuM7`$ԑy`lg'x/Co+K"{ ׁx@޲LCFSҾFXdW{v˦J9?tWnL%i)6{'~i`JF`Ï_;Jn]&."Wq=kf=h=Htl'{ sͿi2~uŦqlֺͳ}mh18]P$OZE2,O"z_;le9נźBl3ć1ڌ^^lIП׾>8k~-j귚k<38C^:ɿL3n\R qL[dyWS-Vլ#1OTᗟ{,Tf8IIğc]~<ڑNOU͛7W* ˏEE07q##|1Z jݝGϼ{A=1}~ڼE]aѹV ec,63pYZ\$ZE$yԜߵ9&ꦶFqMSw&Ю ,N6I>oQ׍xfwHߎksY]p7z5VOw*l8R}ѽCD=HQӇJ{nP ) Pe]z;iVi )^C<3z3>:TJ3Xʒ sy%ki M9'PټOr踒 ,ZOQHtmv2'NNx³|S|`U@ev&;GX.ыddG5t(ő:>Lol 58J@l砐}r9$Q}[h=d"<>;\x_ \5륔͔3}K+[yb( s]s|MS\S|#m?R^g7wV_8=fN_^J[624 ~h{ӧQM]VkRsV`&3A&($J( PPhQ@ "A8E-!bSiԔ! 4FE6ZLSHzӍ4RbIҖ@ 4B(b<wQڐ'6?<-~ n<ȿyGo򇛃彿{彷:mAyiq;P?kF^ԬC>i9$Qa܋A~-y% y2DI|Gv}(`RkW Ǚ:$tGj߆Ab \I\=zͯOUMJ{t<=懕/jt+[sXuK Q\Dk*H~eQU2 S\ؗL h%v'^lZ{O:1+̧%Me >m-?0Lڄ"[9T=Ն\WϺ>-{)䷸P.,Z~Y Tc_ :!5BI 7[]kiRX!}WB[S*of5)FG,/  zWa5s.XךC&Z=kѣ[62zhޠ=&)ΥXRvzpMԿ贮ۧ| ^ԃ8r)%%8 ?IWE%6U2P{Sl/u?)*mZLZ@?xַD%dCvU՛wJmnWA ўsO!,5%)0^;rwٳ_Fx?MKբ[y_L7x_; HdH*GCx ZQ S[#S]˟k5\:qf[z|6=+;/е% z#WšWlW1]A8uў)'^4fnMq_H_% n- Xc? ;\uK9f޾484,T.$}ut|}@ҺǺG]iiӥ}ҢM5C}?U!t=jn}bOz5ݯn韇7gX=X5?J1=oxK6:y5rXuf"17^k@]c=d %J?-a%%áD^:JJF 3,ue }ù䏭w$ ~+>*Riv,sck*׊?V c*N:iJc[K*۔0-ghuo :Sj6F:QZUp%S`OSxߓCr:` rN=(x5m9v~B0ʼY_kVQ1ٗe*2"op:zl˵N Dp}9tFOC "K5#1ۖz+wO 1Ta裡^Weu-I|w[UjWl9\V0Lguk~l| @qW=Gjӈ0P1NqxY]id'ҽ:aG{|&Y [{^3ԏU?SN/Zsׯ, v!(qԃV?<sbx ?-~=Ӯbd`ʀ2d=+@ARpG ReμRR mn"` pGlV' CcֻxZ 0_G#oU=pv6^X_2Dlu|JNlh#b3ɾG&>pY}EV|C/cm2ě8,2N Q\ тN@Oz2s.McPhJJZ(RPi)i) JZJ`!4 IN4cSEiԄSҗ!i )i)ԆHM-&(wJB)CIJi*\~yMy6Ob9J1nm;=۹wfC??ٌ̆h{}?Jlrn c |^ߧ҆Sp<ӷ>fw!y;)@7ma/V'!>/XWK>|ӌ~?C/Ki?O c_,~R?N?Hqsv|q?@xGP?Ϸi\H/ӏpGh :Zr4~5=j4 ~i5>}8 @;y Y>ӏqJVw:kKyWGX@3m?=r\P] ڭ9CRj)3tM]lեq\R"Q1=OU#ްqfjH h* 0F0 9' G2::7̷6jI&!َ$z\MLPض?i[ylx'?U_6[u3gѰ)$ly`G!W.êOoμnhRVG0 J{_>?UbWSeu 2C+ü70+X%=asW1`f=cOTllZEr1"޹洸H9\8Qʺ9W'ޖ"thB~SnǦt䔐J0\f+ӣM6r:rmݎ1QVG~ >}v\[> zW| :χ_Hni-[v^&Լ/pH8u/7H.tO4R-*|ՋSqFCW'1iZzJFƦAaNA~̯[ɼ}|B Kctгpbc?μ~t-jjke2QVoJ@/xicn.K4;r2'f3gxHr?uqkZWN>V_Ɵ/2]Z7@|=kº5:$E㑟J3fpOv UͲ8-Hzw^sYN-5$}_O&K}$0x%d!AaWE:VW hSZƗr «1JRZ{ȊOnz u cn$H#^{Wu6ҠR8F9&!NUŽV\j骒qޱȿC(?IQz7n18LR0A¾X9T20!GxO8R`9Q;ׯj6a$tYHڴ9;&(o[ŭRU2A\1RWKefOWtZܼ#[ǿq\0ԱQ>xpGJc猖iҴ尊VBJI=b8?jda/+su)&G8|?Jh>zů ?Jpq/+[|/ަ 1iҌciҗgq-YG/;oH?ש^4?Jm>pg=ҁgůsͯΔXdx1fU" 6y{V4ox!P'5o%cZVZ[K3l*SkNspzb\W(4vGOm k 4o6 0FE7}ÑMVp@%.^"a u*_48=S}) >a@?_N1X;8"3Ӳף~"g,~|#%[wCOڤU'X g吷˟cUs7Ϥ[I)qX#ב_Ɨ:y1Y(?KҵkMJ6e{>37nW#t5<2@eRl* IWe\8a#SU8H;sh9*^;.r4h1cU8`A+ҧV5֣*oT-0o_SI.OՉ^2𝗉\.>ڼ9tR9Fk/\O;cfZa.Yk^(4{=:vveVN}N%f}v( qjG]ݾ_נ9%Z9ô쟼i@<~u3:VW^MFGol$kd*Uf{tDmF^H*Iu#^xH|^u.mK1~8;9zlsf@Q^<&QJG+FFAQx__US+ m#[? 'tr]|?+~:=MU;GFWm_KG+~?4˸ 4\@㯵sw2FxcGdk.p̂Eݰ<<¹gJjr`vӐAW Hr4wҩexy\c,OozzȾH+f@;džV#NSxVb]QcZӹ[ X79dPz`7#}z=o۹Wm5wI`[`*Hnu덩Yf\nv/?>DtAöIYPrS=q'#_Y%Lx<.@ucp^&O;ppgx{Zu :Q$OpGb+Kԧ~qҦmͰ9 Z}WV,Jo 5oȞ;T`QE%QTRR( !IN=h Q@ 4RJbiIKIM))ƒu)JJSIǽѫZÊ~n}.EZ׭z.{(2NkZv3KK-!k|-idq-`^k1F+9Ҍ'3狫;yAed#ϿTloo>޽^ӯtFD:\ SM,'헝~<;[,R<;#o>u*4 |qoʟ/m\Y[ݱ|OS泮#o2h/"m=ןsJ ji?n976H 7~N?׆ӱpM~kM@̟ Ly7V,w<Ԗ0[^? /ڌ ;T87߷՟B/vctф_4b%nv5w3pLF+GnY񕆫ȴ<sdNQ®3qwFSf-5$ aj57f^iKG5Qt_X}T5SkF mֳuQz\n)ht~5O**Fz?ik )*:3/h7^&eo)2_Hi&0^N}SivZ-\zU[OVVrYCRWrXRz$wL2j|u ~s>RO#5A7(Zَ\d޹$-ؐ9㨮YGYd17O xۦ_$c7^_:Cg'ic| "/Z_ Weͽ_xw o6h#<ͺI+|WŒY8Ӕ~̑@zP?=5=Rɷ[A,׳=Ԁ }<5kY,~=Z\Jj.eB?|eo,;$x g$+PI7Nj)M 9Vo`8"]ǢYFxUo`U0ܦ8'vTђ2z̓NRn-r<`S=bg0uo g?!??ֻSW8>óT;g{SǦq!}=-{IlFE|m Px "n(s㊵.WtzXzs2$'囎ğߡOZo.uIPHP2kr19]ӯo=u1!w!k8-ި ٵtcKa)%>b\g9Wwpjmq(,ٽ5󥇊峇OӦhccQj NZ6{OZ,@%H$d)R2FO*IW(+=U>ΠѩP;ms c߃\OnBOg5跷w-`ReI5Q:kUpʓDD Zuxi7uIKi k?*?'=}s]Q<ʴ9X)i(fHRPM!iRRъcJJZJ`-!!RS) )ޓ)I@hb<{\i{]@*־+# xODZح)E%8u(N QZC}j3]?^5>‚߆t`e8/Zn%|1"WWt5#Zu盛(.dCEpcHϽf#JWuj6J}xwN7P7i\~=:~d?lsH¹jawũnyK<)^~kJidwi<|Oƶu,d+wwF.~W_r i7!CweӞG?Ln't~Iw^mFΔ4sSAC1a'R9=u[ʔOuo<_ZF7/jC$ ;[緓 (Q2mNT7z{3q"[e%D7ګ\VcGHgMG$Qѐy1EahF_hDyMy0[8fa iag;*xw[kn4&/I:vf=Hss޲#dOz/"oMs-"¼xT#.1SG֕^i~/r*xxi3#yqLN<$-*Wsvm!e Uې8y>rd2 }\@7b3&T Bhz펳IF>hۆ_µWΚ~) %ҟH6'A)w3qwDY2×E6\n/kr V[iRH)JV)֕=*QEi J;Vೊ܆a/ ;|k2[s2ƦFyUꦫߑ[SWJ>Mt>ԴqaRmoG"ϨwjAr,Ǹ+M!Q:J{ӯ*{+L65$̧ӊķ]RN8ϵ{g<sKwiJ?3'ּStTAC',C*n,)֌יJ$18?]uPK{{2֙[|ɎT"F}+3e_GcU8C_VrKm-Y 1O־kMsAnlg3tgy\:cmn1up;WmO?59]{?QN5ފե%fa8gLI$FGF$|Qס*p;@ Ӫw_Wx0k#Ҽ7SNh' +7Qޣ>>Fzk*V{$34M ? ˂@ldֽ.\-A1.`OBt'3^+jp9#rT0̘g<-e GEW["]y+t ==k:@dī-ѽuv^O\K @W^Ď} {78%(n-}"c)w.$Bށ4hl[v^5(}?u?*2"JE0T>5GBal4{Y[::;Bj˜9~_N^;wtz<1P{:o6\2)#ras\氿#,UC?΍$M#u'Wq)j`zȣ{~acR?WՆt˟j{.l_A] (Jq@k=6<*%i<`{'x;P-7É޻Z}.#?i+)SZPGzmŀ{k {;Yi?VBZZT J:J+ƸMcKL[HkuZzZ̬7YF};R&R_ >knJi^[F6C1X%x2^(4vjD,<م_?jeJ,e9SUCmğO&-|PnDNwDݪlY#%f?t8FΗo݊鴁9&(#CHe2 ҼAڽ3#)OJt<;kNe~'oֳ>Gk#*wnhDcᐜ=Ese|~7/Q'ʾIX#v?jpZ0gt\+.cZȲ>y$:#VJ9kzVQ(LN$s"Ȼ.Po1ӕ/ռQsic_!n zקwvZo \0o"]CSø[똘%ڪ&q &}'mAq*VPAdW_ŷz@F9*'2Z6eAY ̇_L͢06^kYƛy aqoV+9WduK(i-HXs萏R >%|j1j5B<i Hḥqqzݐ~4Fea}@ ,:ni?Sִir]OI\7Pn'\z~53}t PArkkɫVus ƪ98XΒf|q"W9j.X]xl} cAyS\-XSj+%H̱Jc@@*O|@Ӵ ;?xYzV$|f JحS/:bg.ecpnjw`|%Ȟw#Of5dKr ;6HJɞ㑫i_\X? q+ SZ$:VX*uA0J˷yW7EX5T-#8d+SoH4Mn 2 t~p-SE ەqzJEtJ[kݽq|&V(ˮ>ֻ ޶j)EIY&+I"xfdpհrps'n ܩEЗ?| a/ Sӯy [ʬ0ѻ y =zuѵmVDwn jއr+6PrQ$09#s \=>?τ58(+9RnՌkSUirT qZE_Дu9>?4MLh, V_m2e~_m,e@SV>GN)ZZ/huF! |nǏNJ0O==+< _JdVd~z(דӿՄѴ\^3t RgM`"DOQu$?w è Oe`UTBO:S"ϐ%eQ z؏jk+yu;c `Ngh^%$+U }@~R?uZYo~1玞#c\߈4vku&HOU=FG;nJTCsk[HB\s't8OQ^F>Y=c~SM񥽥BK+)L3{q؂=+i.&𮤾 ؽ}с?sp_g^ԕWJ-]> D(e`jѮymX) -4$)J`%%.hRE-%i)ԄShCM4Ӎ!CJi 0ҚC@4ҊC֘=Q[=cx@7ɚ?xLR^ JZ:Zd?M.[f"җџQKA !Kڐ3/Ĝi}&CEfxĩF-jɥ}4LF6;Wa84+ǿ\COGdBӹx?*z+)SR6ZP]42A qF ;Ȥ- }OBC+C:z((6Ic;YI,>zG 8M?yz+x{lzjZ3:dC|+O2}O}6maX?⵴gfw;0:z1ɹY ujt{őyrVD`"m1GҼ&FI3'&?gQjoA\"$~ ͺ﷓D£d+Y 1o/ѿ/ja GU uj)ibCMl"+/VAo;>D,r-8a:|f%ArFA"fʟxzJo;G#G ECCI:-N=H~~\sO|"pd $29%x\2HZSR҅xwA_Cu]= +Ԑ~yz~}*`%~`hO,Hx4j Q[׃ްo.er\l߿4އr?ĐJ=CEUac?OҴ4YWK[*N*LJ~0T\09V>ic|5o|һu0daT_5-ch_gWzVֳOhy115JOc͍P_i+q-#V]a+vm:1N3V9YcxU6hM(>Ұol$bW׸N%OIny5c"mԯW#'?_sj1KE1Gcn3)6BF@2|y'o!hKmqֽOUG6֙5oQS؏qXΒ7^PjZ.@;ROxKQ$lO|?Ht/Xavָ\\t=XRWFurΑBIUIᯌ2G!vulQEeimA/{tgjhΏ rF5(Cr2*{)>4iwq W؎?O_[7*Xs~+eDžҚ=d'#{~\Iss$n''ە\}/ hGQV<5Zݦde8q~U?+Ajj//?o+ͼL!>դ9Z3$v`2G?b6wWI?_bc#HXmF*5h4- Tu mgF8tx4sdH~r?柎ג\Q1+H5 5M/=cTS.]IO:JEC(e`A5,EoyR(׫4?ލ0x3S3w z]20[m'I2A?)郻lm> O$apo|-# 1Ӟx:u^qּ-xF(./b'CH8,s u մӯP=:G*:Hm˒6sx2; ->k%l2T>|nOJ:\>XgGPRK'%۾CӅ=kVd޼w@]en#ЊmM_ R<` p֮5,G&{M4ө+Ġ4!JO7!!RP!4m0HziwBQE>!R/OݷrddQҷmu[kLlL3J6^ŏZR$A#=[4MjN;S&:}Ǜ?u$Zj+S_~ҝȵ4šA斘Džrohg\SAfʛ6/BK@@KY"G(ZI}E.RP1-bgۏn:+WfA#׽_) s5FicX7:MSܼїt!Gjk(aBzTԍ!^Pjo4)h^W8 F'09fI9޿%Q_sVwȳhdM0ǒ# r9;|DnGI`w(8$Zڊ``sX̱+tvQ-Oj^L*)-N[=)0Ak=N4;d$6qZJnUhJ5Hni/R|֭,Jpdc'קRi>R;jFm/fB6ө?FOL 7F*Σ?ּxeNO]Gb\O-"eHېr +O=+ü7K5ĶOת{:Ҫ+y7X&?֭HZK]n'𯇡!3a,k]":DLj?|9iz2a *)yW6Wr}먌iM9ߎn =.须*etv$K+~9/Rw:oȑiVGk㿊>E5LCNՃGŻ+}oj6ż 2}8!5%i~&kϠu$ þߞpǸ |..585{[%rc1s؃^"f&V%g$$?x5$RCp*2jO.HFhXe9(Nsse7+0A xG9  ѯVV>&`Ptk+Ś-cyYpOҜҫѕͤ{>>CFn~ jͥ^mp }:0<~ +=OI4,l;s?:xWem[H,dVoݽR"c+pG^1 v>TRϨ?E;j0xCl-WvSncdr% k$Q2Gt5ZɭhLTua'8u|v=#q^E]#r8,rN&}6X3:'ȪeV AǰۀkdOH\c Ȭ y>޼ VUzܗvx#ԏc\wv@ CSOo$8!<[NL}QepM;亇GFL05m7Pot~+aYA%紱_L?H%c) ccHx?FS3E <̃ǕJHμy%Oxޣar\IoާqRhw$öH'toT>ʻxXBHK>ؙ>R$o_  O?僜z5SsVUp{uԔ$HÜ9A{WIot$qФJa^c*( :%ù̖ߎTֺG2uᾇSCz#U>w Kpep&_wWPʲG$`)I#--u޵k]$Zm<:ʷ#T'0$H {P׉쵴!- ~{"|psڝIA&))I ŨpUp}UZmFތ:Ms׶rپeF ztq*sʯt[RP)k*+/?ص^u>e<,_C]}_A5rIY;Jڝٮ-%8 ˌ=kBZ}l9+Š ($t$R2c]NϮ9uq t-l9=++S`JH㚗žj i(1"huɩBƽRQɈ5ꟳ#Yp}/ ^nu-ʳ'dgp:qInW;?̿u ;KDߵ^hZ0xUUx3H##k׈߳oі頥t}EvAE" rܞ#><z8\&y 7iCab_n8^k_EMck}{r7pTV%miW4k F55\Gi$d GB{2m:̈́i,;srB1^{i&yg%K9ȯ|)[M;d"hϙc%Ҙ%}i5}+j0#~+i-&hgP 8++pb}?x/ ydZg|`oTz^(sEHƝ^Y=#\䃸Nq?Ni>^\g?tjȍ>IW :xx~5vKY䵝&ȝں[?kM M ,Kdcn{gӱF Nqk]Z\)X.czk9Ǚf};xQUY689Gw4TE-ʏU簯<׎4,Z̳#@S܎Y9&~!s)N[L33UnMhw:pOS,T zwy5~:2Oy{zegW\q v=F{ ZjSv#O秸={ף i'c/Y[fw2A?3ٮ.`Lu=q}GC]]`XHiRO5fo"z^5K33s;Cctۺ-;gBo3o!#BYǛ&-8':Ƶ<9C[I-/ $=xJvGߖ=r(L@rz q뙖]Zu;?`Ofס)+ǜ%EU⒖i)i HsKIMi4ژ“84bC@K.tC?5t}*GHuDV;u(AQҊQ@ɹ5WCUoRymB4qntye3=f-߈ը؀/`pol>a}"~Ԭ;+Y[GT{V>JKcj ?*.ĺ'Diͤ/BDD2|@Q+.l*/lGZu1 ('~ZU0헼8FAފZŹZ5G[ӟHM/uJ)hgE" }frU]>=i(i<~h_bNtCbop͉#?t1幇?!]DV99.}Qm1)9l?ңƨ4ѯH;sP!fOo?\%- K? # 8a&D/,\ KmiBY- "'i.̝JCB <U~SQ()+27F(JލOMD܁'79>یFT܈eO7ot^h^w[gktUUKzGOIɅױ8i3ϯRs7#ۿjO(J[,[>i<{vx9ʻLOqzji|[us(YFr:jMKб,un 2AV3iDs1'eqګ֓pV@\6|kŻHO>#zנϺ?aLM 7dy2[3ǓTDJAjofhLx+khzM'#?ljo^LRnbB$=YGLץm~տB(:?iFUa" Kґ))4x%m|y\]?0 s!+ ?J3<Qm¯ ]}z:ŴUHUt.UA\՞MVF9Z ǡQA- f$>195#nVpצ̏o$d% NqZ9cut5|G, K 8+F= bx{˯xS+e<*}5b5%(.cԭ5Wtz{sSN;G~UIJd@+ԏP+/*{~pkthx](-D D3nF m'pOL#D8R9$=:=*ޑ-w 9n Sǯ.#V G:u#5W`c)8;AI/ydZlE@*Wj5YS~mU{g*).=N=hr9'qa{{U۷/YTq7N᫅E(Lgf| `[r+gzkɓգKDȼCWRW$Q?OҼ\޸dwGr?ޯ_1Z09sL@H>]Ya]+QOʑvu+.*}TkҼ9EqF99Ibn7T5eK#mss޽sNNJߦܐJ?z4ў}z^tzdEt` Wyh4}iCHM/zFBf)i )bSHzSRQABQE%·\tUMw@/#t*{b(zu%-5G/Qm_R.;"E-%Xo,CX_k=WӛQb}c5 u:iIΙj*MjZ~%mxvez'\~r(2 WQ}}l>KWEU-Oe8ZE%k'O ϸX?QVKޒ4\AT\Uڥ_A!MEz \zSGj(mE7K㦝lo(?I2ER?JMzbDY`sQImL-]%'*3qMcB%^XIItݹ5ƥZVVT#{^qkIeiI/8uRTwQg HQe!QpT¹屘&kfN6HϠ'7ݥ7F'DιZ;$Y$Er!voMbWWνǽLʢDF9Lq<X,ϖwO$eV^BSB2U2/'sǴf2ҥvnqm"C>ҷ[8 3=ܱ}g_V/4ې3ϕOjS֝FApjʾktR/\t>^Zpj9"x+Ks{ PI*Io&$,=@Q-nj~\+Ex>?27A@RU8#j%<%㈯JZa<,Ͽ=k8`۟`8?z*)K/ek.c{Uw3{um*} c= 5a}o-Ť,MЯo:P7Ÿ8#ZucU]EZ2vǟ|UwS?ghfs)XE̜8qU-|zevv(eh|>fGi`RjN-1xcP&ή ~ӉƏ7nhOt,; KZʒ*@+>3Lg;*p;0GAwgֿnOU?𯟵E}L>{wv<~̟9@B.Z7ecj@gְk2n,zιиuQU.OqT5߳?S$w|a1Uw4igX@#GP $y0~v_7T?Uh+(Al0p8G.7юQեs5X3yk- Q= N9]om/|o/̂/p+sρzbC+kFy9x84XvI<\t8aI9=?4r6co#1%7n./M"0IaQK&ҡVszֹ1?߈=+z,no~čhykO9\g҄=wŒf#EG ޼hUO^q/a[.aǭtpes1z.A^%hQ'x"+[ .Hv'ߵWݥ8s֕i# f2yVFG~1*;zww3毥=ԫi5WzvWXW2^91*Ѫ ?~~4^-WN6Q_r>*˓ʩ^c< ɦ_BMY&f4s]x\7 ~8X+,N ֽ7>%>!-­>FCfcva6eYc4uw!LBRR擩CHiM4cQE'jN)ƛҀsY{Ħ>QE.?* +^X[ uYOF;1 (z7㏭i 2Q,.D$ ڶ \O:1F)<OWԴgQ 2F֕v6ES-yC2<2B"KOʩ EAJ) J(8΅[h8+A~ƅKh8)zR TՎ4U wP=Ŵ4 2]|S, 7?{xrú!^=1Hꮥ\SdPR6i@QѥG0xFo8VKFY"9d@퉓61z<Eev?o Fk{~?#q\([cХRќFfq! p#hJl˅D+l'7ct )%1ިhU&!8RC(}G73GRwخT'2n$~//"-I?ߕLC*t|gTo_o]41~ ۟G_>Vs&~?/iWPZMlm$zzzҳʠI9UǪ7//k>˭LQA‹ q$-чob; Q eLr=Ta[>$;ј?{}Tu:UU-\Ra͊oJޥ;fTtkcmu_3}zVwEjgrLV8_9-n?ljٶ;,!9qkϊ8Dž5DDKU1=˄"ϋNKF5J\WjVR>pcQkhf,d7[DtL5lz(n,#K茲FxP?Op~a޼ٸc;Ǧ7n~h9=WM;; Mb|r!|AiweȆB7?1*itg9߮qgaX% H:tdP(?!$~U=#;T 5B Z9KC)I#(>޽0{p}k<[ L$cNIXzv1T\GM y,nU.O$vs m^;a0 F$Uӥs%CèЀnM>$ytbXqcL:N(u<i=0{}y$RB6I}=?^)-p9GWVqhNL$WE*J)GЌ}2?k亚ohh3BymN$}O®WTw[ϖE:6d,R_lWM\jpL) -%hd!šihCM%-%13Enh&T+sLV Wֺ}ys@fe=h·Zjbֆʂ 2bu4SWglIٟB5k? GecTS(bSH){P\ez΃a\i3΁a\!4u2E SҀ3! ¯ZH?iIWAOdSӭHRuFvG5\!1^jbV!w^ǾUqwQڋar V`B\#5Z[(d[b+tTGe,KHxʐr!fJnp#o?Iֽ'>(U?,XZ=&OrXI|= 7TэS`ǻv>Hxg3"1U)#(jk)N~1fjT+P.U@}coNwq4R`yp18}Yя,ݿ R8<_+$|!I[Kr &DWϲ<OcL~rs8ZDڻzɹQzqkFER bn- <uEUJ2V~ltaSȩ8 8X~ Ջ^XQu/vV7w-ўl~]|cqCpLi9) V_3q%,ۼy/G>+]J'ez{e,pKdxGEqL|ۢ?yob=kYKnKxX2?QWe(:k@KÖӸ޺9βֽ3a> +[H7jUp`jwsi x $kmJ2$+.k؅R+#5"Xd5#̬U9K<6fJͻt{cpkY|0SCKk$K+z|m#ktRu;SGMSnN-JHI@>|w>(-$}Lm:_,˴șn}W7.s=J$և~~!F4[˅[y[w:ᑇjKvx-$eee8 w yFw9sZ>n"irwkg<%+.~_U#7^q=|M|r8jGF}߆]:Cgh| `D˒ZPyFKOH ?|+ԵKTžՒ2Zg~UαahPrj*r?? [q]g7=c{zd#fqt$W+ïyciXBU%5!zN7hjvi3ͦ᱐r=zg"cC_y\\8oUѺ?~:6)?\V-5"D`Qs=R/9ISӿ?Fs|%MkxHQ( l#pG㸮QeI +goξ}zwϠ =peaÞ }\8huS9 YW)у}L@T Hkε bp\0WXGvG0^ܨtgMjs=ڼ^b܅*@@zk-Ѓ#xK8R<}O= rT5R^&uğ1࣎t?Xi%]GqԢibSўjL1oOpz%}cJ̝Fv?*ϥfc [ibnr\>j@sA?y>g +fE})F62̣o]"@]hG<Eu: xc\߆IqA0qG4g[a9A~<66r( ʁO}H.3`qWRr;N 'H]@ޡco#:CMGy*xL٢HKMfT/f#P)8h༏ ;[j KdNU Elbd]|mz"x~㏻'W7oYrKOfi3{y`{X#$ tȒF NAU[TQg_ +s۟W^DZ-m%5x\(2&-Mh:Jě[gKx0&0:eҾr-:ry`o>nr_7#'*7 d8S}N$ac!$٦9{ڮQ$Q` ;s>xOlujO㴐,P)SW-ySKLh>%'+^x]/ÍB-;5\Q#HgjԖs4Ksv$tqȦ`eIȯHbnh\y{`}TO4vz+:_)ΛIO\y&cNӾ{Pg6,LcW1 #v-[??TIOգK!Rq捎+Z[̗Yq~5t|n7k4|ɹq:H;g@п8#?*$flG^?C0 O {8{tX fvשl`w9 Xs篯NWE-gmg5:}zꢤg==L'c֮{$UT;G׿+t+q,r:C+I 0l!)`½Oþdpgf<1z==ʼnc-vdW+)\}퀮9$}_ƴ00x>}GqY(]i7 H:`zr;W~3_]i*r'KK-;]Gg(!Rɿ?xK}7XgPDnwF?_jRnr-${OÙnrK#.GVQiC?ﳴlwcz {zJ[F*Ѵ0i 0RRJJ RRm1ES&Εe\#E:T#A6?+N2KbwQL,Veiu0Tgv3msx?mv8?kSU&4Kk4SJ6_ ̸##?J^Ye?9:bfisYp]L{K s9 x+'ÿzd~Ai=Ys#IH襈p~Udvbd3/E!.9T ꇱ5+Ԣ.7 yOH΋5:n,S6)Z/,z^F"#?k~͏ ;HH=aQgL]%v?){Wjih^+ \u Cxm *ʼ09ט w?eǙٝyZ7;"7jԂuar+,B NSWcL9`!@cOҸSW;SFtҲ#q֭Pڰ*ʆ+QX dO%=jF3 92f#[2;DuRg۬yLO^j6U}?&[I737Xq]_|A>2ϧ^3''fB\ho2R Z5MnKjq?yMiJUe=AU75j9Ґ3)zU:Uy)ʛaTPetuj usapzm4u(%̬L_+Te ]Ekov{?ϭ}-q}WmFkirO7-eoam#@cp,=g|qI#!'2\g3QT 7NvyzwGh ~Llǐ>4| u~hco^!V*s^#Q%JUYgGhPDl5ٖѺqAH_캣rO%m+ؤjyWۭiBjS4z';FD'i^ 4-|UA㞵]Gaq+v?^zS4;moIܻdݕ?O^1O0Ha_}=zԵv8-)\,{0A np w+wS?ɬ-CC2ۆ3ėcӧ`@f\ Κ1_ ><){:O?x_$񍄱У1 a߯}d>ޤ+HZ 9@iƒfCIZ 744B<=et*f @/Stq@}Nh%E(R@P8:Vvf$%BESRtO! JxsR?~d?j<:&6VC#~cV0 J,Y,{iEī=WCV4N>)yԧu(-^8&% HFC  w( [Y 7,Qzf*6Q()niNLJؖk&f}*ēh?J5Zԋk}>Waָ[Ylo |㪞ιJJ3p3i%vǥyk US(w.w5 !W<`oj婹ه~T@C;?+TַYeʐpI0ǾgO\v>'*9(/95?U(8ܽQ]=DF,Op*Wi{j4U.#XeY z - ]N&KTɱ8<ּrWOSfBB<:UsD{"2~gJԌƴL͢mp62S^?kq,Rb>hX|EZu-|KW>IߑUmOM3[z 5XlXGv#!%<,uAJ4Nzՙ F^"/eOMfH@w%dUu!lVeWTxo]d`9PSO\S#^$G"28*Ef]Hܿt~LjMSPyk2qw/,5u2U#^}JN'B9 B2*\iw^X\ز 3ǵf Q.$tC c"*_B@|7U> }R>?W+tVZ/3ĬObA*GqzV ^TsF^\lcG2y:ʱ:"c=tvM]T*ȬI3?}}i"k A ǽ|o:AHfЬ$m*N꽾1Kc@Ph04N&iE'4bނ(B<=et4״_:غ -PhYݿ?RRY)hEQ@U{C4QRƶf2щL֎^>6Z40GFY]UA jwAI?+Ht@) P"żV?֯ (h:EJc=dVj?P( M4Q@#7JPjExZ d'VOE(Oj_QU#Xr8?^EɱSVJo)(QE\U;S(QA!ڪ5>((krRԴmFyȝO=A2g;5I3I!"/`{kOT-ʗL,V$8&ϐQPqM\E{pwIդ+۶?笣0vpNŽC2=h&-V}+YNEVW*CX9'1̧Ҋ+Ϩz)6P\ To@.}N+ 1&Ҥvu<#4QY1KĐZ-iA^$zJM}4 v?EW<;GYja_n[.v_o4F mj qzz(C7%WA)(4Q@ 4QT#
Warning: fopen(https://newsweekme.com/wp-content/uploads/2016/08/2016-08-01T093420Z_3_LYNXNPEC700TY_RTROPTP_3_GSK-BRITAIN-780x439.jpg): failed to open stream: HTTP wrapper does not support writeable connections in /home/newsweekme/public_html/wp-includes/class-wp-image-editor.php on line 428

GlaxoSmithKline and Google parent Alphabet's life sciences unit are creating a new company focused on fighting diseases by targeting electrical signals in the body. REUTERS/Toby Melville/File Photo

By Ben Hirschler

LONDON – GlaxoSmithKline and Google parent Alphabet’s life sciences unit are creating a new company focused on fighting diseases by targeting electrical signals in the body, jump-starting a novel field of medicine called bioelectronics.

Verily Life Sciences – known as Google’s life sciences unit until last year – and Britain’s biggest drugmaker will together contribute 540 million pounds ($715 million) over seven years to Galvani Bioelectronics, they said on Monday.

The new company, owned 55 percent by GSK and 45 percent by Verily, will be based at GSK’s Stevenage research center north of London, with a second research hub in South San Francisco.

It is GSK’s second notable investment in Britain since the country voted to leave the European Union in June. Last week it announced plans to spend 275 million pounds on drug manufacturing.

Galvani will develop miniaturized, implantable devices that can modify electrical nerve signals. The aim is to modulate irregular or altered impulses that occur in many illnesses.

GSK believes chronic conditions such as diabetes, arthritis and asthma could be treated using these tiny devices, which consist of a electronic collar that wraps around nerves.

Kris Famm, GSK’s head of bioelectronics research and president of Galvani, said the first bioelectronic medicines using these implants to stimulate nerves could be submitted for regulatory approval by around 2023.

“We have had really promising results in animal tests, where we’ve shown we can address some chronic diseases with this mechanism, and now we are bringing that work into the clinic,” he told Reuters.

“Our goal is to have our first medicines ready for regulatory approval in seven years.”

GSK first unveiled its ambitions in bioelectronics in a paper in the journal Nature three years ago and believes it is ahead of Big Pharma rivals in developing medicines that use electrical impulses rather than traditional chemicals or proteins.

The tie-up shows the growing convergence of healthcare and technology. Verily already has several other medical projects in the works, including the development of a smart contact lens in partnership with the Swiss drugmaker Novartis that has an embedded glucose sensor to help monitor diabetes.

GRAIN OF RICE

Famm said the first generation of implants coming to market would be around the size of a medical pill but the aim eventually was to make them as small or smaller than a grain of rice, using the latest advances in nanotechnology.

Patients will be treated with keyhole surgery and the hope is that bioelectronic medicine could provide a one-off treatment, potentially lasting decades.

Major challenges including making the devices ultra low-power so that they function reliably deep inside the body.

The idea of treating serious disease with electrical impulses is not completely new.

Large-scale electrical devices have been used for years as heart pacemakers and, more recently, deep brain stimulation has been applied to treat Parkinson’s disease and severe depression, while EnteroMedics last year won U.S. approval for a device to help obese people control their appetite.

Galvani, however, is taking electrical interventions to the micro level, using tiny implants to coax insulin from cells to treat diabetes, for example, or correct muscle imbalances in lung diseases.

Galvani will initially employ around 30 scientists, engineers and clinicians.

The company will be chaired by Moncef Slaoui, GSK’s vaccines head, who pioneered the drugmaker’s drive into the bioelectronics field. Slaoui is retiring from GSK next March but will continue to steer Galvani after that date, a spokesman said.

Galvani will be fully consolidated in GSK’s financial statements, following the model of the group’s majority-owned ViiV Healthcare business, which sells HIV medicines.

Social Streams

Comments

comments

Facebook Comments

Post a comment